Bitterroot Bio
Pioneering cardio-immunology to transform cardiovascular medicine
- Headquarters
- Palo Alto, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- bitterrootbio.com
- Total Funding
- $145.0M
- Last Round
- $145.0M Series AJun 2023
About
Bitterroot Bio is a biotech company committed to pioneering cardio-immunology. Co-founded 2021 by Dr. Irv Weissman and Dr. Nick Leeper at Stanford. $145M Series A led by ARCH and Deerfield.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account